United Therapeutics Overview
United Therapeutics Target Price
Analysts' 12-month price predictions for UTHR.
Get informed when a big investor buys or sells
+ FollowShare Price
$531.79
Average Target Price
$641.60
20.6% upside
20.6% upside5 analysts in the last 4 months
High: $738 | Low: $516
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-07 | Morgan StanleyTerence Flynn | $516 |  3% downside |  |
| 2026-05-07 | Wells Fargo | $735 | 38.2% upside | |
| 2026-05-07 | Wells Fargo | $738 | 38.8% upside | |
| 2026-04-10 | Morgan StanleyTerence Flynn | $519 | 2.4% downside | |
| 2026-04-10 | Raymond James | $700 | 31.6% upside | |
| 2026-03-12 | Cantor FitzgeraldOlivia Brayer | $625 | 17.5% upside | |
| 2026-02-26 | H.C. WainwrightAndrew Fein | $600 | 12.8% upside | |
| 2026-01-06 | UBS | $645 | 21.3% upside | |
| 2025-11-19 | JefferiesEun Yang | $575 | 8.1% upside | |
| 2025-10-30 | H.C. WainwrightAndrew Fein | $525 | 1.3% downside | |
| 2025-10-30 | RBC CapitalLisa Walter | $587 | 10.4% upside | |
| 2025-10-29 | Morgan StanleyTerrance Flynn | $447 | 15.9% downside | |
| 2025-10-10 | Morgan StanleyTerence Flynn | $435 | 18.2% downside | |
| 2025-09-29 | UBS | $580 | 9.1% upside | |
| 2025-09-26 | RBC Capital | $569 | 7% upside | |
| 2025-09-10 | Cantor FitzgeraldOlivia Brayer | $525 | 1.3% downside | |
| 2025-09-05 | H.C. WainwrightAndrew Fein | $500 | 6% downside | |
| 2025-09-02 | JefferiesRoger Song | $564 | 6.1% upside | |
| 2025-07-31 | H.C. WainwrightAndrew Fein | $400 | 24.8% downside | |
| 2025-04-25 | Wells FargoTiago Fauth | $314 | 41% downside | |
| 2024-10-31 | Argus ResearchJasper Hellweg | $400 | 24.8% downside | |
| 2024-10-31 | H.C. WainwrightAndrew Fein | $425 | 20.1% downside | |
| 2024-09-23 | JefferiesEun Yang | $432 | 18.8% downside | |
| 2024-08-28 | OppenheimerHartaj Singh | $575 | 8.1% upside | |
| 2024-07-08 | UBSAshwani Verma | $370 | 30.4% downside | |
| 2024-06-12 | Wells FargoTiago Fauth | $350 | 34.2% downside | |
| 2024-05-02 | OppenheimerHartaj Singh | $400 | 24.8% downside | |
| 2024-02-12 | Goldman SachsChris Shibutani | $215 | 59.6% downside | |
| 2023-01-11 | Argus Research | $300 | 43.6% downside | |
| 2022-12-06 | Morgan Stanley | $330 | 37.9% downside | |
| 2022-12-06 | UBS | $320 | 39.8% downside | |
| 2022-12-05 | Goldman Sachs | $230 | 56.7% downside | |
| 2022-05-24 | J.P. Morgan | $238 | 55.2% downside | |
| 2022-05-24 | Jefferies | $245 | 53.9% downside | |
| 2022-05-24 | Credit Suisse | $247 | 53.6% downside | |
| 2022-05-24 | H.C. Wainwright | $255 | 52% downside | |
| 2022-04-19 | J.P. Morgan | $223 | 58.1% downside | |
| 2021-05-05 | Credit SuisseTiago Fauth | $205 | 61.5% downside | |